RegenThera’s patented drying technology is a powerful platform technology that is applicable to
virtually all biological samples.
Our platform technology combined with regenerative medicine-based therapeutics (Extractome®)
opens drug development opportunities to address unmet needs in a wide range of inflammatory and
Extractome® has many benefits, including long-term storage stability at RT and concentration control. Moreover, Extractome® powder can be simply reconstituted in water for direct intravenous or intraarticular injection, or incorporated into delivery vehicle for transdermal or intranasal delivery. Versatility of Extractome® opens more opportunities for its clinical application.
Versatile delivery routes
Address unmet needs in inflammatory and degenerative diseases